Exclusive

Publication

Byline

Location

Clinical Trial: Topical Capsaicin Versus Diclofenac for Chronic Temporomandibular Joint-Related Pain

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07598994) titled 'Topical Capsaicin Versus Diclofenac for Chronic Temporomandibular Joint-Related Pain' on May... Read More


Clinical Trial: Trajectory-Based Phenotyping After Coronary Artery Bypass Surgery

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07598682) titled 'Trajectory-Based Phenotyping After Coronary Artery Bypass Surgery' on May 07. Brief Summary... Read More


Clinical Trial: Tolerability of Remimazolam Versus Midazolam in EUS

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07600073) titled 'Tolerability of Remimazolam Versus Midazolam in EUS' on April 27. Brief Summary: This study... Read More


Clinical Trial: Emulation of the RECORD3 Trial Using Healthcare Claims Data

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599384) titled 'Emulation of the RECORD3 Trial Using Healthcare Claims Data' on May 14. Brief Summary: Inve... Read More


Clinical Trial: Effect of Diosmin/Hesperidin Combination on Platinum Compounds-Induced Nephropathy in Cancer Patients

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07598214) titled 'Effect of Diosmin/Hesperidin Combination on Platinum Compounds-Induced Nephropathy in Cancer... Read More


Clinical Trial: LONG PULSED ND:YAG LASER (1064 NM) VERSUS INTENSE PULSED LIGHT IN TREATMENT OF TRAUMATIC AND POST-SURGICAL ERYTHEMATOUS SCARS

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599709) titled 'LONG PULSED ND:YAG LASER (1064 NM) VERSUS INTENSE PULSED LIGHT IN TREATMENT OF TRAUMATIC AND... Read More


Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, May 21 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension (PALM-PAH)

Singapore, May 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evalu... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, May 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, May 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More